Status:
UNKNOWN
New Perspective on Exploring the Post-apneic BP Surge in Patients With OSA
Lead Sponsor:
Xu J
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18-65 years
Phase:
EARLY_PHASE1
Brief Summary
The nocturnal short-term BPV induced by sleep-breathing events is affected by many factors. The purpose of the study is as follows: (1) to explore the relationship between nocturnal short-term BPV and...
Detailed Description
It has been known that nocturnal short-term blood pressure variability (BPV) is a special phenomenon in obstructive sleep apnea (OSA) patients. Nocturnal short-term BPV is a quantitative measure that ...
Eligibility Criteria
Inclusion
- medium to severe OSA (apnea-hypopnea index, AHI≥15 events/h) and patients without OSA (AHI\<5 events/h)
- age from 18 to 65 years old.
Exclusion
- combined with other sleep disorders
- patients with comorbidities, such as hypertension, diabetes, cardiovascular diseases, and cerebrovascular diseases etc
- conditions that potentially affect the accuracy of BPV and endothelial function
- ever-received the treatment of constructive positive airway pressure (CPAP)
- who refuse to participate in the study.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT06172998
Start Date
April 1 2022
End Date
June 1 2024
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jing Xu
Huai'an, Jiangsu, China, 223300